absolutely.
www.orthmed.org
Orthomolecular medicine describes the practice of preventing and treating disease by providing the body with optimal amounts of substances which are natural to the body. The term "orthomolecular" was first used by Linus Pauling in a paper he wrote in the journal Science in 1968. The key idea in orthomolecular medicine is that genetic factors affect not only to the physical characteristics of individuals, but also to their biochemical milieu. Biochemical pathways of the body have significant genetic variability and diseases such as atherosclerosis, cancer, schizophrenia or depression are associated with specific biochemical abnormalities which are causal or contributing factors of the illness. Want to learn more? The following essays give a more detailed overview of the nature, efficacy and history of orthomolecular medicine.
Genetically triggered criminality and its environmental roots... better believe it.
www.HRIPTC.org
Reduced violent behavior following biochemical therapy
William J. Walsh, , Laura B. Glab and Mary L. Haakenson
Pfeiffer Treatment Center, 4575 Weaver Parkway, Warrenville, IL 60555, United States
Received 5 May 2003; revised 23 June 2004; accepted 29 June 2004. Available online 11 September 2004.
Abstract
Reduced violent behavior following biochemical therapy. We conducted an outcome study to measure the effectiveness of biochemical therapy for 207 consecutive patients presenting with a diagnosed behavior disorder. The treatment protocols were based on clinical evaluation and our past experience in the treatment of 8000 patients with behavior disorders at the Pfeiffer Treatment Center (PTC) over a 10-year period. Each test subject was screened for chemical imbalances previously found in high incidence in this population, including metal-metabolism disorders, methylation abnormalities, disordered pyrrole chemistry, heavy-metal overload, glucose dyscontrol, and malabsorption. The clinical procedure included a medical history, assay of 90 biochemical factors, and a physical examination. Standardized treatment protocols were applied for each imbalance that was identified. The frequencies of physical assaults and destructive episodes were determined using a standardized behavior scale before and after treatment, with follow-up ranging from 4 to 8 months.
Results
Seventy-six percent of the test subjects achieved compliance during the treatment period. The remaining 24% were reported to have discontinued the therapy. A reduced frequency of assaults was reported by 92% of the compliant assaultive patients, with 58% achieving elimination of the behavior. A total of 88% of compliant destructive patients exhibited a reduced frequency of destructive incidents and 53% achieved elimination of the behavior. Statistical significance was found for reduced frequency of assaults (t=7.74, p<0.001) and destructive incidents (t= 8.77, p<0.001). The results of this outcome study strongly suggest that individualized biochemical therapy may be efficacious in achieving behavioral improvements in this patient population.
Keywords: Violent behavior; Biochemical therapy; Chemical imbalance
Index terms: Chemical imbalance; Behavior; Assaultiveness; Rages; Nutrient therapy; Metal-metabolism; Metallothionein; Methylation; Pyrroles; Lead; Malabsorption; Copper; Zinc